Jpmorgan Chase & CO Aziyo Biologics, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 43 shares of AZYO stock, worth $62. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43
Previous 29
48.28%
Holding current value
$62
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AZYO
# of Institutions
31Shares Held
12.2MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$4.15 Million0.25% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.51MShares$3.64 Million1.47% of portfolio
-
Silverarc Capital Management, LLC1.65MShares$2.39 Million0.59% of portfolio
-
Birchview Capital, LP Burlington, VT1.32MShares$1.92 Million1.77% of portfolio
-
Knollwood Investment Advisory, LLC Hunt Valley, MD935KShares$1.36 Million0.41% of portfolio
About AZIYO BIOLOGICS, INC.
- Ticker AZYO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,308,720
- Market Cap $13.5M
- Description
- Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...